4//SEC Filing
Niklason Laura E 4
Accession 0001818382-24-000177
CIK 0001818382other
Filed
Sep 2, 8:00 PM ET
Accepted
Sep 3, 4:23 PM ET
Size
7.2 KB
Accession
0001818382-24-000177
Insider Transaction Report
Form 4
Humacyte, Inc.HUMA
Niklason Laura E
DirectorPresident, CEO and Director
Transactions
- Purchase
Common Stock
2024-08-29$6.54/sh+1,222$7,998→ 242,054 total
Holdings
- 510,161(indirect: By Spouse)
Common Stock
- 1,148,240(indirect: By Trust)
Common Stock
- 3,677,262(indirect: By LLC)
Common Stock
Footnotes (1)
- [F1]This purchase is matchable under Section 16(b) of the Securities Exchange Act of 1934, as amended, against a portion of the sale by Ayabudge LLC, an entity controlled by the Reporting Person's spouse, of 809,786 shares of the Issuer's common stock on May 31, 2024. The Reporting Person has paid the Issuer $3,391.05, representing the full amount of profit realized in connection with this purchase.
Documents
Issuer
Humacyte, Inc.
CIK 0001818382
Entity typeother
Related Parties
1- filerCIK 0001878075
Filing Metadata
- Form type
- 4
- Filed
- Sep 2, 8:00 PM ET
- Accepted
- Sep 3, 4:23 PM ET
- Size
- 7.2 KB